PYC Therapeutics Limited

A$1.88As of Sun 8 Nov 2026, 12:00 UTC
ASX:PYCHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 27.76%
Div yield —
ROE (10.14%)
Biotechnology
Beta (5Y) 1.07
PE TTM —
TSR TTM 52.79%
Mkt cap A$1.850B
ROIC (8.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.14
13.59%
293.50%
Hold 9|3|1|12|0
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.04
0.04
0.04
0.05
16.63%
16.14%
5.67%
5.68%
Revenue$M
195.9
192.4
189.8
189.9
(2.55%)
(1.52%)
(5.20%)
(4.63%)
Peers (US$1.271B)
Cap (US$)
PE
1.810B
—
Capital
TTM
5Y
10Y
Leveragex
0.408
(0.138)
(0.124)
EBIT/Intx
1.645
0.518
0.469
Own earn%
(21.72)
(18.62)
(25.44)
Sh yield%
49.94
29.16
27.09
Owners
Insiders/Inst%
2.99
35.52
Short interest%
5.89
SBC / revenue%
2.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
0–9
$1 testx
0.0
Incr. ROIC%
32